Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists for these regions, from 2014 to 2025 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists market competition by top manufacturers/players, with Glucagon like peptide-1 (GLP-1) agonists sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists for each application, includin
Hospital
Pharmacy
Other

Table of Contents

Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market Report 2019
1 Glucagon like peptide-1 (GLP-1) agonists Overview
1.1 Product Overview and Scope of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists by Product Category
1.2.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market Size (Sales) Comparison by Types (2014-2024)
1.2.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Exenatied
1.2.4 Liraglutide
1.2.5 Lixisenatide
1.2.6 Albiglutide
1.2.7 Dulaglutide
1.3 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market by Application/End Users
1.3.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales (Volume) and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market by Region
1.4.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market Size (Value) Comparison by Region (2014-2024)
1.4.2 China Status and Prospect (2014-2024)
1.4.3 Japan Status and Prospect (2014-2024)
1.4.4 South Korea Status and Prospect (2014-2024)
1.4.5 Taiwan Status and Prospect (2014-2024)
1.4.6 India Status and Prospect (2014-2024)
1.4.7 Southeast Asia Status and Prospect (2014-2024)
1.4.8 Australia Status and Prospect (2014-2024)
1.5 Asia-Pacific Market Size (Value and Volume) of Glucagon like peptide-1 (GLP-1) agonists (2014-2024)
1.5.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2014-2024)
1.5.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2024)

2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists (Volume and Value) by Type
2.2.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists (Volume) by Application
2.4 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists (Volume and Value) by Region
2.4.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Region (2014-2019)

3 China Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
3.1 China Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
3.1.1 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
3.1.2 China Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
3.1.3 China Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
3.2 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
3.3 China Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

4 Japan Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
4.1 Japan Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
4.1.1 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
4.1.3 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
4.2 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
4.3 Japan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

5 South Korea Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
5.1 South Korea Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
5.1.1 South Korea Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
5.2 South Korea Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
5.3 South Korea Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

6 Taiwan Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
6.1 Taiwan Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
6.1.1 Taiwan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
6.2 Taiwan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
6.3 Taiwan Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

7 India Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
7.1 India Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
7.1.1 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
7.1.2 India Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
7.1.3 India Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
7.2 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
7.3 India Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

8 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
8.1 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
8.1.1 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
8.2 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
8.3 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

9 Australia Glucagon like peptide-1 (GLP-1) agonists (Volume, Value and Sales Price)
9.1 Australia Glucagon like peptide-1 (GLP-1) agonists Sales and Value (2014-2019)
9.1.1 Australia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2014-2019)
9.1.3 Australia Glucagon like peptide-1 (GLP-1) agonists Sales Price Trend (2014-2019)
9.2 Australia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Type
9.3 Australia Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Market Share by Application

10 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Players/Suppliers Profiles and Sales Data
10.1 Novo Nordisk
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 AstraZeneca
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Eli Lilly
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 GSK
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 GSK Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Sanofi
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 Bristol-Myers Squibb
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Amylin
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Glucagon like peptide-1 (GLP-1) agonists Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Amylin Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
...

11 Glucagon like peptide-1 (GLP-1) agonists Manufacturing Cost Analysis
11.1 Glucagon like peptide-1 (GLP-1) agonists Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2018
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Market Forecast (2019-2024)
15.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Price Forecast (2019-2024)
15.1.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate Forecast (2019-2024)
15.1.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2019-2024)
15.1.3 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Price and Trend Forecast (2019-2024)
15.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Volume and Growth Rate Forecast by Region (2019-2024)
15.2.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast by Region (2019-2024)
15.2.3 China Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.4 Japan Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.5 South Korea Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.6 Taiwan Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.7 India Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.8 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.2.9 Australia Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Growth Rate Forecast (2019-2024)
15.3 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue and Price Forecast by Type (2019-2024)
15.3.1 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Type (2019-2024)
15.3.2 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Revenue Forecast by Type (2019-2024)
15.3.3 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Price Forecast by Type (2019-2024)
15.4 Asia-Pacific Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Application (2019-2024)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us